unknown
Stage
2024
Founded
1
Investors
About
Belenos Biosciences develops long-acting bispecific antibody therapeutics targeting key pathways in chronic inflammatory diseases such as asthma, COPD, and atopic dermatitis to provide durable and comprehensive control of immune and tissue-level inflammation.
Explore Belenos Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.